Technology Development & Commercialization News Archives
25.05.2010 - UHN Joins iBridge to Highlight Latest Biomedical Licensing Opportunities as iBridge’s First Canadian Partner. Read more...
21.04.2010 -
UHN and UHN’s Technology Development and Commercialization office were delighted to present Dr. Mohammad Islam and Dr. Michael Sharpe with UHN’s Inventor of the Year award for 2009. This award, presented at the recent Board of Trustees retreat on April 21st. Read more...
11.04.2010 - UHN - Trillium expands immunology pipeline and enters stem cell field through in-licensing of two new programs. Read more...
30.11.2009 -
Over the last four years a team of scientists at the Princess Margaret Hospital have developed, in partnership with Precision X-Ray Inc, the first commercially produced small animal Image Guided X-Ray Irradiation System, the X-RAD 225Cx. Read more...
14.10.2009 - TDC recently negotiated an exclusive license and collaboration agreement with the Vancouver biotechnology company MedBioGene Inc. to further develop this ground-breaking prognostic genomic analysis for early stage non-small cell lung cancer. Read more...
16.09.2009 - Release of the 2009 UHN Technology Licensing Opportunities
15.07.2009 - UHN, OICR and Pfizer Colorectal Cancer Collaboration. Read more...
16.06.2009 - TDC would like to announce the release of the TDC-UHN Inaugural Research Commercialization report. To view the report click here.
04.04.2006 - Amorfix Life Sciences in-Licenses second novel technology to strengthen its ALS therapeutic program. Read more...
All content viewed in UHN News archives is the sole property of the University Health Network
and cannot be used, copied, duplicated, referred to or streamed without the express written
permission of the University Health Network. All Rights Reserved.
